These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28560883)

  • 1. A deletion mutation in nfxB of in vitro-induced moxifloxacin-resistant Pseudomonas aeruginosa confers multidrug resistance.
    Thai VC; Pham HV; Nguyen DNM; Lambert P; Nguyen TTH
    Acta Microbiol Immunol Hung; 2017 Sep; 64(3):245-253. PubMed ID: 28560883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa.
    Poole K; Gotoh N; Tsujimoto H; Zhao Q; Wada A; Yamasaki T; Neshat S; Yamagishi J; Li XZ; Nishino T
    Mol Microbiol; 1996 Aug; 21(4):713-24. PubMed ID: 8878035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates.
    Pasca MR; Dalla Valle C; De Jesus Lopes Ribeiro AL; Buroni S; Papaleo MC; Bazzini S; Udine C; Incandela ML; Daffara S; Fani R; Riccardi G; Marone P
    Microb Drug Resist; 2012 Feb; 18(1):23-32. PubMed ID: 21797666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EsrC, an envelope stress-regulated repressor of the mexCD-oprJ multidrug efflux operon in Pseudomonas aeruginosa.
    Purssell A; Fruci M; Mikalauskas A; Gilmour C; Poole K
    Environ Microbiol; 2015 Jan; 17(1):186-98. PubMed ID: 25143244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-Time Monitoring of
    Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa.
    Purssell A; Poole K
    Microbiology (Reading); 2013 Oct; 159(Pt 10):2058-2073. PubMed ID: 23924707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the exoU genotype with a multidrug non-susceptible phenotype and mRNA expressions of resistance genes in Pseudomonas aeruginosa.
    Takata I; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jan; 24(1):45-52. PubMed ID: 29107652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa.
    Higgins PG; Fluit AC; Milatovic D; Verhoef J; Schmitz FJ
    Int J Antimicrob Agents; 2003 May; 21(5):409-13. PubMed ID: 12727072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
    Jalal S; Wretlind B
    Microb Drug Resist; 1998; 4(4):257-61. PubMed ID: 9988043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa.
    Kiser TH; Obritsch MD; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2010 Jul; 30(7):632-8. PubMed ID: 20575627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa.
    Vestergaard M; Paulander W; Marvig RL; Clasen J; Jochumsen N; Molin S; Jelsbak L; Ingmer H; Folkesson A
    Int J Antimicrob Agents; 2016 Jan; 47(1):48-55. PubMed ID: 26597931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
    Zheng J; Cui S; Meng J
    J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
    Jeannot K; Elsen S; Köhler T; Attree I; van Delden C; Plésiat P
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2455-62. PubMed ID: 18474583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
    Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
    J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa.
    Stickland HG; Davenport PW; Lilley KS; Griffin JL; Welch M
    J Proteome Res; 2010 Jun; 9(6):2957-67. PubMed ID: 20373734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.
    Chuanchuen R; Beinlich K; Hoang TT; Becher A; Karkhoff-Schweizer RR; Schweizer HP
    Antimicrob Agents Chemother; 2001 Feb; 45(2):428-32. PubMed ID: 11158736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Detection of OXA-10 Extended-Spectrum Beta-Lactamases and the Occurrence of mexR and nfxB in Clinical Isolates of Pseudomonas aeruginosa from Nigeria.
    Odumosu BT; Adeniyi BA; Chandra R
    Chemotherapy; 2016; 61(2):87-92. PubMed ID: 26606515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719.
    Cao L; Srikumar R; Poole K
    Mol Microbiol; 2004 Sep; 53(5):1423-36. PubMed ID: 15387820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa.
    Kriengkauykiat J; Porter E; Lomovskaya O; Wong-Beringer A
    Antimicrob Agents Chemother; 2005 Feb; 49(2):565-70. PubMed ID: 15673734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.